Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 702
Selected: 0
NCT IDTitle
NCT00548834Efficacy and Safety of CDP870 Versus Placebo in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis
NCT02497976Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis
NCT01263925Prostaglandin E1 in Outpatients With Intermittent Claudication
NCT00761774An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam
NCT03021018A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting
NCT01793103Brigham and Women's Rheumatoid Arthritis Sequential Study
NCT03992196A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome
NCT03766685A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)
NCT00244387Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa
NCT02326298An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)
NCT00160615Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method
NCT00596752Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV
NCT00490035Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
NCT00291655Follow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly Diagnosed Epilepsy Coming From N01175 (NCT00175903).
NCT06380816A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
NCT00519532Long-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects With Idiopathic Parkinson's Disease
NCT06425549A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis
NCT03215277A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis
NCT04075409A Study to Test the Safety, and Tolerability of Padsevonil in Healthy Male Japanese Study Participants
NCT00150709A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy
NCT03410992A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT01450111To Evaluate the Pharmacokinetics and Safety/Tolerability of Lacosamide in 3 Dosages in Healthy Male Korean Subjects
NCT00247364A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)
NCT00655486Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures
NCT01707186Pictorial Representation of Illness and Self Measure
NCT00610454Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures
NCT01964573Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects
NCT00252954Levetiracetam in Chronic Neuropathic Pain Following Spinal Cord Injury
NCT04658186A 18-month Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Oral UCB0599 in Study Participants With Early-stage Parkinson's Disease
NCT01069419Observation of Treatment With Certolizumab Pegol in Daily Practice
NCT00227461Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.
NCT03010527A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis
NCT05028127A Study to Evaluate the Relative Bioavailability and Tolerability of Bimekizumab in Healthy Subjects
NCT01407523An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures
NCT00422110A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures
NCT01606670Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease
NCT00813774Bio-availability Comparison of Three Formulations of Certolizumab Pegol in Healthy Volunteers
NCT00439712Levocetirizine in the Treatment of Nasal Obstruction Due to Perennial Allergic Rhinitis
NCT01300819Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor Symptoms
NCT02495844A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy
NCT01118949Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
NCT00370838Comparison of Keppra and Clonidine in the Treatment of Tics
NCT00175890A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.
NCT07215949Zilucoplan for Severe gMG Exacerbations
NCT04185415A Study to Test the Safety and Tolerability of UCB0107 in Study Participants With Progressive Supranuclear Palsy (PSP)
NCT02873767A First-In-Human Study With a Single Dose UCB4019 in Healthy Volunteers
NCT03020992A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU
NCT06590493Doxecitine and Doxribtimine-Expanded Access
NCT00223587Seasonal Allergic Rhinitis and Driving Ability
NCT03532516Compassionate Use Program With Brivaracetam for the Treatment of Patients With Epilepsy